Epsilon Healthcare (ASX:EPN) — Material Events
ASX:EPN · 11 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Epsilon Healthcare Surges 96% in Q4 Receipts, Reinstated on ASXMedium
Epsilon Healthcare Posts Record Q4 Receipts, Reinstated to ASX, Eyes Expansion
28 Jan 2026
·Quarterly Activities Report and Appendix 4C
·85
Epsilon Healthcare Surges with Record $2.9M Quarter, Cuts Debt Post-AdministrationMedium
Epsilon Healthcare Reports Record Q3 2025 Receipts and Debt Reduction Post-Voluntary Administration
7 Nov 2025
·Quarterly Activities Report and Appendix 4C
·85
Epsilon Healthcare Posts Record $3.14M Receipts, Accelerates Growth TrajectoryMedium
Epsilon Healthcare Delivers Record $3.14M Quarterly Receipts, 154% YOY Growth
30 Apr 2026
·Quarterly Activities Report and Appendix 4C
·85
Epsilon Healthcare’s 2025 Turnaround: Revenue Surges, Losses Narrow SharplyMedium
Epsilon Healthcare reports strong revenue growth and reduced loss in 2025, driven by CDMO and new Pharmacy division
27 Feb 2026
·Preliminary Final Report
·80
Epsilon Healthcare Charts Clear Path to ASX Reinstatement with Solid FinancialsMedium
Epsilon Healthcare prepares for ASX reinstatement with improved financials and strategic growth plan
18 Dec 2025
·Pre-Reinstatement Disclosure
·80
Epsilon Pharma Secures AU$6M Deal to Manufacture Cannabis Products for UK and EuropeMedium
Epsilon Pharma inks 3-year AU$6M manufacturing deal with Puro NZ for UK and European cannabis market expansion
5 Feb 2026
·ASX Release
·80
Epsilon Healthcare Surges 73% in Revenue, Eyes Sustained GrowthMedium
Epsilon Healthcare posts 73% revenue growth in June quarter, strengthens financial position
7 Nov 2025
·Quarterly Activities Report and Appendix 4C
·75
Epsilon Healthcare Boosts Revenue 19% Amid Restructuring but Posts Larger LossMedium
Epsilon Healthcare reports 19% revenue growth but wider net loss; completes $6.7M sale-leaseback and capital raise amid ASX suspension
16 Dec 2025
·Appendix 4D and Consolidated Interim Financial Report
·75
Epsilon Healthcare Launches Pharmacy, Extends Loan Amid Operational ResetMedium
Epsilon Healthcare stabilizes operations, launches pharmacy, extends loan facility, and anticipates growth
7 Nov 2025
·Quarterly Activities Report and Appendix 4C
·70
Epsilon Healthcare Set to Resume Trading on ASX TomorrowMedium
Epsilon Healthcare to Resume Trading on ASX from 19 December 2025
18 Dec 2025
·Reinstatement to Quotation
·60
Epsilon Healthcare’s MD Injects $2M Loan, Defers Director Payments to 2027Medium
Epsilon Healthcare secures $2M loan from MD and defers director payments to 2027 to strengthen working capital
18 Dec 2025
·Shareholder Update
·60
No articles in this tier for the last 12 months.
Market Mentions
4
- appeared in market wrap coverage
These are market wrap articles where Epsilon Healthcare (ASX:EPN) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Healthcare Wrap - Week 6 (2 Feb -> 6 Feb) 2026
7 Feb 2026
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026